Concentra Group Holdings Parent, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US20603L1026
USD
21.91
-0.89 (-3.9%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

258.27 k

Shareholding (Dec 2025)

FII

7.09%

Held by 92 FIIs

DII

40.55%

Held by 65 DIIs

Promoter

0.51%

Is Concentra Group Holdings Parent, Inc. overvalued or undervalued?

21-Oct-2025

As of October 17, 2025, Concentra Group Holdings Parent, Inc. is considered overvalued at a price of 19.92, with a valuation grade of expensive, reflecting underperformance against the S&P 500 and a lack of peer comparisons.

As of 17 October 2025, the valuation grade for Concentra Group Holdings Parent, Inc. moved from very expensive to expensive, indicating a slight improvement in perceived value but still suggesting that the stock is not attractively priced. The company appears to be overvalued given its current price of 19.92, especially when considering its recent performance against the S&P 500, where it has underperformed across multiple periods, including a 1-year return of -5.73% compared to the S&P 500's 14.08%.<BR><BR>Key valuation ratios for Concentra include a price-to-earnings (P/E) ratio that is not specified but suggests a premium valuation, alongside a lack of peer comparisons that would typically provide context. The absence of comparable companies further complicates the assessment, but the overall market sentiment and the company's negative returns relative to the S&P 500 reinforce the conclusion that Concentra Group Holdings is overvalued at this time.

View full answer

Is Concentra Group Holdings Parent, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Concentra Group Holdings Parent, Inc. shows a mildly bearish trend, with weekly MACD and Bollinger Bands indicating bearishness, a 6.88% decline over the past week, and underperformance compared to the S&P 500.

As of 31 October 2025, the technical trend for Concentra Group Holdings Parent, Inc. has changed from bearish to mildly bearish. The weekly MACD and Bollinger Bands indicate a bearish stance, while the moving averages are also bearish on a daily basis. The Dow Theory supports a mildly bearish view on both weekly and monthly time frames. There are no signals from the RSI or KST, and the OBV shows no trend. Over the past week, the stock has declined by 6.88%, while the S&P 500 has gained 0.71%. In the past month, the stock is down 6.7%, compared to a 1.92% increase in the S&P 500. Overall, the technical stance is mildly bearish, reflecting weakness relative to the benchmark.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 2,910 Million (Small Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-79.90

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
539 Million
(Quarterly Results - Dec 2025)
Net Profit:
36 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.67%
0%
11.67%
6 Months
4.23%
0%
4.23%
1 Year
5.08%
0%
5.08%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Concentra Group Holdings Parent, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
5.70%
EBIT Growth (5y)
66.71%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
19.23%
Pledged Shares
0
Institutional Holding
96.82%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
NA
EV to EBIT
3.57
EV to EBITDA
3.26
EV to Capital Employed
-35.42
EV to Sales
1.31
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
NA

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 74 Schemes (51.01%)

Foreign Institutions

Held by 92 Foreign Institutions (7.09%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -5.88% vs 3.99% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -27.31% vs 7.79% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "539.10",
          "val2": "572.80",
          "chgp": "-5.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "91.70",
          "val2": "116.60",
          "chgp": "-21.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "31.80",
          "val2": "29.40",
          "chgp": "8.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "3.20",
          "val2": "-1.40",
          "chgp": "328.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "36.20",
          "val2": "49.80",
          "chgp": "-27.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "132.40%",
          "val2": "168.80%",
          "chgp": "-3.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.85% vs 3.38% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.52% vs -6.93% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,163.40",
          "val2": "1,900.20",
          "chgp": "13.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "421.40",
          "val2": "371.70",
          "chgp": "13.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "110.30",
          "val2": "69.70",
          "chgp": "58.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.40",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "172.80",
          "val2": "171.90",
          "chgp": "0.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "159.70%",
          "val2": "160.20%",
          "chgp": "-0.05%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
539.10
572.80
-5.88%
Operating Profit (PBDIT) excl Other Income
91.70
116.60
-21.36%
Interest
31.80
29.40
8.16%
Exceptional Items
3.20
-1.40
328.57%
Consolidate Net Profit
36.20
49.80
-27.31%
Operating Profit Margin (Excl OI)
132.40%
168.80%
-3.64%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -5.88% vs 3.99% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -27.31% vs 7.79% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
2,163.40
1,900.20
13.85%
Operating Profit (PBDIT) excl Other Income
421.40
371.70
13.37%
Interest
110.30
69.70
58.25%
Exceptional Items
-11.40
0.00
Consolidate Net Profit
172.80
171.90
0.52%
Operating Profit Margin (Excl OI)
159.70%
160.20%
-0.05%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 13.85% vs 3.38% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 0.52% vs -6.93% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details